Amazon.com, Inc. (AMZN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN)

AMZN 229.12

-0.2%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Rose who wrote (108488)	9/15/2000 4:56:41 PM
From: H James Morris	Read Replies (2) of 164684

Rob, a little Biotech down here in San Diego just went over the top. >Corvas International is engaged in the design and development of a new generation of therapeutic agents in thefields of blood clot formation (thrombosis), inflammation, cancer and other diseases. For the 6 months ended 06/30/00,total revenues rose 33% to $4.4M. Net loss fell 4% to $4.5M. Results are attributable to a $2.5M license fee from Schering-Plough, partially offset by increased R&D expenses related to the clinical trial of rNAPc2.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next